Respiratory Literature Service, issue 3 (1999): a sponsored digest
Archive record. Copy preserved by the Internet Archive on 24 August 2000.
Original title: Asmanet ARLS 3-1999 Astra Respiratory Literature Service Experts comments
This historical document is not current medical guidance. Read the original copy
Key points
- A pharmaceutical company’s literature digest: ten journal articles on asthma and allergy, each with a short expert comment.
- Reviewers were named; one commentary came from an employee of the sponsoring company.
- Captured on 24 August 2000; page last updated 13 May 2000.
- Sponsored commentary from 1998 to 1999: not independent review, and not current medical advice.
What this page was
The page republished issue 3 of 1999 of the "Respiratory Literature Service" (ARLS), a literature digest produced for specialists by the pharmaceutical company AstraZeneca. The page stated that the company supplied the service, and that the AsmaNet team had reformatted the comments as web pages with links to abstracts and references. It was last updated on 13 May 2000 and captured by the web archive on 24 August 2000. This was sponsored literature, and its commentary should be read in that light.
What it covered
Ten recent journal articles were listed with their authors, journals and reviewers. The reviewers named were Dr Lars Larsson (listed with the sponsor's research and development unit), Associate Professor Leif Rosenhall, Professor Estelle Simons, Professor Duncan Geddes and Professor Philippe Godard. The topics covered asthma drug trials, a study of immunoglobulin in severe steroid-dependent asthma, exhaled nitric oxide as a marker, peak flow variation in children, the effects of early treatment on hospital admissions, glucocorticoid-insensitive asthma, treatments for allergic rhinitis and the effect of long-term inhaled steroids on bone. Full commentary on each article and, in places, the abstract followed. The page also noted the company's support for a European federation of asthma and allergy associations.
What has changed
These are 1998 to 1999 papers chosen and discussed in a manufacturer-supported publication. This record names no products and makes no recommendation, and nothing in the digest should guide a treatment decision today. Dosing, safety and best practice have changed. Speak to your clinician about your own treatment.
Related pages
AsmaNet publishes educational information that does not replace advice from a doctor or occupational health professional. If someone is struggling to breathe, call your local emergency number. This content has not been reviewed by a clinician.